Effects of screening strategies to detect carbapenem-resistant gram-negative bacteria: A systematic review

被引:8
|
作者
Verdugo-Paiva, Francisca [1 ]
Otaiza, Fernando [2 ]
Roson-Rodriguez, Pablo [1 ]
Rojas-Gomez, Ana Maria [1 ]
Galas, Marcelo [2 ]
El Omeiri, Nathalie [2 ]
Fuentes, Yackelin [2 ]
Rada, Gabriel [1 ,3 ]
Ramon-Pardo, Pilar [2 ]
机构
[1] Epistemonikos Fdn, Santiago, Chile
[2] World Hlth Org PAHO WHO, Pan Amer Hlth Org, Antimicrobial Resistance Special Program, Communicable Dis & Environm Determinants Hlth, 525 23 Rd St NW, Washington, DC 20037 USA
[3] Pontificia Univ Catolica Chile, Fac Med, Internal Med Dept, Santiago, Chile
关键词
Carbapenem resistance; Enterobacteriaceae; Acinetobacter; Pseudomonas; Surveillance; Systematic review; KLEBSIELLA-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; FINDINGS TABLES; ENTEROBACTERIACEAE; INFECTION; OUTBREAK; IMPACT; INTERVENTION; PROGRAM;
D O I
10.1016/j.ajic.2022.02.018
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: This systematic review aims to summarize the evidence on the effects of screening strategies to detect carbapenem-resistant gram-negative bacteria (Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa).Methods: Eligible studies were randomized trials, non-randomized controlled trials, controlled before-after studies, and interrupted time series. We conducted searches in CENTRAL, PUBMED, Embase, Epistemonikos, and in multiple databases available in the Virtual Health Library (LILACS, Scielo, WHO IBECS, and PAHO IBECS). All the searches covered the period until 4 June 2021. No date or language restrictions were applied. Two reviewers independently evaluated potentially eligible studies according to predefined selection crite-ria, and extracted data on study characteristics, methods, outcomes, and risk of bias, using a predesigned standardized form. When possible, we intended to conduct meta-analyses using a random-effect model. We assessed the certainty of the evidence (CoE) and summarized the results using the GRADE approach.Results: Our search strategy yielded 57,451 references. No randomized trials were identified. Sixteen studies (one controlled before-after study and 15 interrupted time series) met our inclusion criteria and were included in the review. Most studies were conducted in tertiary care general hospitals from the United States, Europe, and Asia. Eleven studies included adult patients hospitalized in general wards and intensive care units, one was carried out in a neonatal intensive care unit, two in hematology or oncology units, and one in a solid organ transplantation department. Eleven studies were conducted in the setting of an outbreak. Regarding the detection strategy used, all studies included screening strategies for high-risk patients at the moment of admission and 7 studies reported a contact surveillance strategy. Most studies were conducted in settings where infection prevention and control measures were concomitantly installed or reinforced. Data were not suitable for meta-analysis, so the results were presented as a narrative synthesis. Most studies showed a decline in the prevalence of both infection and colonization rates after the implementation of a pol-icy of active surveillance, but the CoE is low. Screening strategies may result in little to no difference in the risk of all-cause mortality and the length of hospital stay.Conclusions: Existing evidence may favor the use of surveillance culture to carbapenem-resistant gram -neg-ative bacteria, but its quality is poor, so solid conclusions cannot be drawn. Well-conducted randomized trials or high-quality quasi-experimental studies are needed to improve the certainty of the existing evidence. These studies should assess the effect of the addition of screening strategies as a single intervention and mea-sure clinically important outcomes such as infection, length of hospital stay, and mortality.(c) 2022 The Author(s). Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
引用
收藏
页码:1381 / 1388
页数:8
相关论文
共 50 条
  • [1] Screening for carbapenem-resistant Gram-negative bacteria
    Lee, Sang Hee
    Jeong, Seok Hoon
    Cha, Sun-Shin
    LANCET INFECTIOUS DISEASES, 2006, 6 (11): : 682 - 684
  • [2] Infective endocarditis by carbapenem-resistant Gram-negative bacteria - a systematic review
    Pitsikakis, Konstantinos
    Skandalakis, Michail
    Fragkiadakis, Konstantinos
    Baliou, Stella
    Ioannou, Petros
    GERMS, 2024, 14 (02): : 149 - 161
  • [3] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Paul, Mical
    Carmeli, Yehuda
    Durante-Mangoni, Emanuele
    Mouton, Johan W.
    Tacconelli, Evelina
    Theuretzbacher, Ursula
    Mussini, Cristina
    Leibovici, Leonard
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (09) : 2305 - 2309
  • [4] Worldwide proliferation of carbapenem-resistant gram-negative bacteria
    Kurokawa, H
    Yagi, T
    Shibata, N
    Shibayama, K
    Arakawa, Y
    LANCET, 1999, 354 (9182): : 955 - 955
  • [5] Combination therapy for carbapenem-resistant Gram-negative bacteria
    Zavascki, Alexandre P.
    Bulitta, Jurgen B.
    Landersdorfer, Cornelia B.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2013, 11 (12) : 1333 - 1353
  • [6] Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
    Jean, Shio-Shin
    Harnod, Dorji
    Hsueh, Po-Ren
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [7] The global threat of carbapenem-resistant gram-negative bacteria
    Dropa, Milena
    Daoud, Ziad
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [8] Editorial: New therapeutic strategies against carbapenem-resistant gram-negative bacteria
    Mascellino, Maria Teresa
    Oliva, Alessandra
    Biswas, Silpak
    Ceccarelli, Giancarlo
    FRONTIERS IN MICROBIOLOGY, 2024, 15
  • [9] Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review
    Palacios-Baena, Zaira R.
    Giannella, Maddalena
    Manissero, Davide
    Rodriguez-Bano, Jesus
    Viale, Pierluigi
    Lopes, Sara
    Wilson, Katy
    McCool, Rachael
    Longshaw, Christopher
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (02) : 228 - 235
  • [10] Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
    Garg, Atul
    Garg, Jaya
    Kumar, Sachin
    Bhattacharya, Amitabh
    Agarwal, Saurabh
    Upadhyay, G. C.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2019, 149 (02) : 285 - 289